Get Started

GOVX

NASD GeoVax Labs, Inc.
Oct 30, 2026 · 9:35 PM ET EOD Market Closed

$0.1686 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.1686, $0.0162 below the day’s high of $0.1848

YTD change
-96.06%
vs 20-day SMA
-31.96%
vs 200-day SMA
-86.74%

Price ranges

Previous day
$0.1834 $0.2000
open $0.1920 close $0.1859
-$0.0061 (-3.18%)
Today
$0.1651 $0.1848
open $0.1788 now $0.1686
-$0.0102 (-5.70%)
Past week
$0.1834 $0.2271
from $0.2127 now $0.1686
-$0.0441 (-20.73%)
Past month
$0.1834 $0.4600
from $0.3222 now $0.1686
-$0.1536 (-47.67%)
This year
$0.1551 $4.4000
from $4.2750 now $0.1686
-$4.1064 (-96.06%)

Price & Performance

-0.92 (-84.53%) / 6M

$-0.1091$1.23$2.58$3.92Apr 30Jul 31Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $13,125.0000
  • GOVX is down 96% since the beginning of the year
  • GOVX is down 99% over the past 12 months
  • GOVX is down 48% over the past 1 month
  • 2% of all GOVX investors are betting against GOVX

GOVX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -70.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.97
Earnings momentum +11.0% Quarterly EPS growth
Quarterly change +11.0%

Valuation

P/E ratio N/A
Enterprise value $-1971610.0
Beta 3.08

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$3.1M
Debt$323.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.2M

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.